Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation ExpenseLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Orchestra BioMed Holdings (OBIO) Depreciation Expense (2024 - 2025)

Historic Depreciation Expense for Orchestra BioMed Holdings (OBIO) over the last 2 years, with Q3 2025 value amounting to $81000.0.

  • Orchestra BioMed Holdings' Depreciation Expense rose 657.89% to $81000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $329000.0, marking a year-over-year change of. This contributed to the annual value of $308000.0 for FY2024, which is 731.71% up from last year.
  • According to the latest figures from Q3 2025, Orchestra BioMed Holdings' Depreciation Expense is $81000.0, which was up 657.89% from $81000.0 recorded in Q2 2025.
  • Orchestra BioMed Holdings' Depreciation Expense's 5-year high stood at $84000.0 during Q4 2024, with a 5-year trough of $74000.0 in Q1 2024.